<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Inmode Ltd — News on 6ix</title>
<link>https://6ix.com/company/inmode-ltd</link>
<description>Latest news and press releases for Inmode Ltd on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Mon, 13 Apr 2026 04:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/inmode-ltd" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo683583ef78dffbe2df0fce5f.webp</url>
<title>Inmode Ltd</title>
<link>https://6ix.com/company/inmode-ltd</link>
</image>
<item>
<title>InMode to Report First Quarter 2026 Financial Results and Hold Conference Call on May 6, 2026, Expects Q1 Revenue Between $81.5M-$81.7M, Reiterates FY 2026 Revenue Guidance Between $365M-$375M</title>
<link>https://6ix.com/company/inmode-ltd/news/inmode-to-report-first-quarter-2026-financial-results-and-hold-conference-call-on-may-6-2026-expects-q1-revenue-between-dollar815m-dollar817m-reiterates-fy-2026-revenue-guidance-between-dollar365m-dollar375m</link>
<guid isPermaLink="true">https://6ix.com/company/inmode-ltd/news/inmode-to-report-first-quarter-2026-financial-results-and-hold-conference-call-on-may-6-2026-expects-q1-revenue-between-dollar815m-dollar817m-reiterates-fy-2026-revenue-guidance-between-dollar365m-dollar375m</guid>
<pubDate>Mon, 13 Apr 2026 04:00:00 GMT</pubDate>
<description>Conference call to be held on Wednesday, May 6, 2026, at 8:30 a.m. Eastern TimeYOKNEAM, Israel, April 13, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a</description>
</item>
<item>
<title>InMode to Present at the 25th Annual Needham Virtual Healthcare Conference</title>
<link>https://6ix.com/company/inmode-ltd/news/inmode-to-present-at-the-25th-annual-needham-virtual-healthcare-conference</link>
<guid isPermaLink="true">https://6ix.com/company/inmode-ltd/news/inmode-to-present-at-the-25th-annual-needham-virtual-healthcare-conference</guid>
<pubDate>Tue, 24 Mar 2026 04:00:00 GMT</pubDate>
<description>YOKNEAM, Israel, March 24, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that</description>
</item>
<item>
<title>InMode Announces New Share Repurchase Program</title>
<link>https://6ix.com/company/inmode-ltd/news/inmode-announces-new-share-repurchase-program-80</link>
<guid isPermaLink="true">https://6ix.com/company/inmode-ltd/news/inmode-announces-new-share-repurchase-program-80</guid>
<pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
<description>YOKNEAM, Israel, March 13, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that</description>
</item>
<item>
<title>InMode Announces Conclusion of Independent Transaction Committee Review</title>
<link>https://6ix.com/company/inmode-ltd/news/inmode-announces-conclusion-of-independent-transaction-committee-review</link>
<guid isPermaLink="true">https://6ix.com/company/inmode-ltd/news/inmode-announces-conclusion-of-independent-transaction-committee-review</guid>
<pubDate>Mon, 23 Feb 2026 05:00:00 GMT</pubDate>
<description>YOKNEAM, Israel, Feb. 23, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) a leading global provider of innovative medical technologies ("InMode" or the</description>
</item>
<item>
<title>InMode Reports Fourth Quarter and Full Year 2025 Financial Results: Quarterly GAAP Revenue of $103.9 Million and Full Year Revenue of $370.5 Million</title>
<link>https://6ix.com/company/inmode-ltd/news/inmode-reports-fourth-quarter-full-120000023</link>
<guid isPermaLink="true">https://6ix.com/company/inmode-ltd/news/inmode-reports-fourth-quarter-full-120000023</guid>
<pubDate>Tue, 10 Feb 2026 12:00:00 GMT</pubDate>
<description>InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the fourth quarter and full year of 2025.</description>
</item>
<item>
<title>InMode to Participate in the 13th Annual BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference</title>
<link>https://6ix.com/company/inmode-ltd/news/inmode-participate-13th-annual-btig-medtech-digital-health-life-sciences-diagnostics</link>
<guid isPermaLink="true">https://6ix.com/company/inmode-ltd/news/inmode-participate-13th-annual-btig-medtech-digital-health-life-sciences-diagnostics</guid>
<pubDate>Tue, 03 Feb 2026 05:00:00 GMT</pubDate>
<description>YOKNEAM, Israel, Feb. 3, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that</description>
</item>
<item>
<title>InMode Responds to Transaction Rumors</title>
<link>https://6ix.com/company/inmode-ltd/news/inmode-responds-transaction-rumors-2026-02-02</link>
<guid isPermaLink="true">https://6ix.com/company/inmode-ltd/news/inmode-responds-transaction-rumors-2026-02-02</guid>
<pubDate>Mon, 02 Feb 2026 05:00:00 GMT</pubDate>
<description>YOKNEAM, Israel, Feb. 2, 2026 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technologies ("InMode" or the</description>
</item>
<item>
<title>InMode to Report Fourth Quarter & Full Year 2025 Financial Results and Hold Conference Call on February 10, 2026, Expects Q4 Revenue Between $103.6M-$103.8M</title>
<link>https://6ix.com/company/inmode-ltd/news/inmode-report-fourth-quarter-full-year-2025-financial-results-and-hold-conference</link>
<guid isPermaLink="true">https://6ix.com/company/inmode-ltd/news/inmode-report-fourth-quarter-full-year-2025-financial-results-and-hold-conference</guid>
<pubDate>Thu, 08 Jan 2026 05:00:00 GMT</pubDate>
<description>Conference call to be held on Tuesday, February 10, 2026, at 8:30 a.m. Eastern TimeYOKNEAM, Israel, Jan. 8, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a</description>
</item>
<item>
<title>InMode Reports Third Quarter 2025 Financial Results: Quarterly Revenue of $93.2 Million, 78% Gross Margins</title>
<link>https://6ix.com/company/inmode-ltd/news/inmode-reports-third-quarter-2025-financial-results-quarterly-revenue-932-million-78</link>
<guid isPermaLink="true">https://6ix.com/company/inmode-ltd/news/inmode-reports-third-quarter-2025-financial-results-quarterly-revenue-932-million-78</guid>
<pubDate>Wed, 05 Nov 2025 05:00:00 GMT</pubDate>
<description>YOKNEAM, Israel, Nov. 5, 2025 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD) ("InMode"), a leading global provider of innovative medical technologies, today</description>
</item>
<item>
<title>InMode Appoints Michael Dennison as President of North America</title>
<link>https://6ix.com/company/inmode-ltd/news/inmode-appoints-michael-dennison-president-north-america-2025-11-03</link>
<guid isPermaLink="true">https://6ix.com/company/inmode-ltd/news/inmode-appoints-michael-dennison-president-north-america-2025-11-03</guid>
<pubDate>Mon, 03 Nov 2025 05:00:00 GMT</pubDate>
<description>IRVINE, Calif., Nov. 3, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, has appointed Michael</description>
</item>
<item>
<title>InMode to Participate in Upcoming Investor Conferences</title>
<link>https://6ix.com/company/inmode-ltd/news/inmode-participate-upcoming-investor-conferences-2025-10-30</link>
<guid isPermaLink="true">https://6ix.com/company/inmode-ltd/news/inmode-participate-upcoming-investor-conferences-2025-10-30</guid>
<pubDate>Thu, 30 Oct 2025 04:00:00 GMT</pubDate>
<description>YOKNEAM, Israel, Oct. 30, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the</description>
</item>
<item>
<title>InMode to Report Third Quarter 2025 Financial Results and Hold Conference Call on November 5, Expects Q3 Revenue Between $92.5M-$93.0M, Reiterates FY 2025 Guidance Between $365M-$375M</title>
<link>https://6ix.com/company/inmode-ltd/news/inmode-report-third-quarter-2025-financial-results-and-hold-conference-call-november</link>
<guid isPermaLink="true">https://6ix.com/company/inmode-ltd/news/inmode-report-third-quarter-2025-financial-results-and-hold-conference-call-november</guid>
<pubDate>Thu, 09 Oct 2025 04:00:00 GMT</pubDate>
<description>Conference call to be held on Wednesday, November 5, 2025, at 8:30 a.m. Eastern Time YOKNEAM, Israel, Oct. 9, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD),</description>
</item>
<item>
<title>InMode to Present at Baird 2025 Global Healthcare Conference</title>
<link>https://6ix.com/company/inmode-ltd/news/inmode-present-baird-2025-global-healthcare-conference-2025-09-02</link>
<guid isPermaLink="true">https://6ix.com/company/inmode-ltd/news/inmode-present-baird-2025-global-healthcare-conference-2025-09-02</guid>
<pubDate>Tue, 02 Sep 2025 04:00:00 GMT</pubDate>
<description>YOKNEAM, Israel, Sept. 2, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that</description>
</item>
<item>
<title>InMode Reports Second Quarter 2025 Financial Results: Quarterly Revenue of $95.6 Million, 80% Gross Margins</title>
<link>https://6ix.com/company/inmode-ltd/news/inmode-reports-second-quarter-2025-financial-results-quarterly-revenue-956-million-80</link>
<guid isPermaLink="true">https://6ix.com/company/inmode-ltd/news/inmode-reports-second-quarter-2025-financial-results-quarterly-revenue-956-million-80</guid>
<pubDate>Wed, 30 Jul 2025 04:00:00 GMT</pubDate>
<description>YOKNEAM, Israel, July 30, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today</description>
</item>
<item>
<title>InMode to Report Second Quarter 2025 Financial Results and Hold Conference Call on July 30, Expects Q2 Revenue Between $95.4M-$95.5M, Decreases Full Year 2025 Revenue Guidance to be Between $365M-$375M</title>
<link>https://6ix.com/company/inmode-ltd/news/inmode-report-second-quarter-2025-financial-results-and-hold-conference-call-july-30</link>
<guid isPermaLink="true">https://6ix.com/company/inmode-ltd/news/inmode-report-second-quarter-2025-financial-results-and-hold-conference-call-july-30</guid>
<pubDate>Thu, 10 Jul 2025 04:00:00 GMT</pubDate>
<description>Conference call to be held on Wednesday, July 30, 2025, at 8:30 a.m. Eastern Time YOKNEAM, Israel, July 10, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a</description>
</item>
<item>
<title>InMode Response Letter to DOMA by Moshe Mizrahy, CEO, Dated May 28, 2025</title>
<link>https://6ix.com/company/inmode-ltd/news/inmode-response-letter-doma-moshe-mizrahy-ceo-dated-may-28-2025-2025-05-28</link>
<guid isPermaLink="true">https://6ix.com/company/inmode-ltd/news/inmode-response-letter-doma-moshe-mizrahy-ceo-dated-may-28-2025-2025-05-28</guid>
<pubDate>Wed, 28 May 2025 04:00:00 GMT</pubDate>
<description>YOKNEAM, Israel, May 28, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today sent</description>
</item>
<item>
<title>InMode Announces Health Canada Certification of the IgniteRF Platform with the New QuantumRF Technology</title>
<link>https://6ix.com/company/inmode-ltd/news/inmode-announces-health-canada-certification-131700479</link>
<guid isPermaLink="true">https://6ix.com/company/inmode-ltd/news/inmode-announces-health-canada-certification-131700479</guid>
<pubDate>Tue, 20 May 2025 13:17:00 GMT</pubDate>
<description>InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, is pleased to announce Health Canada certification of IgniteRF, an advanced platform offering a comprehensive suite of minimally invasive radiofrequency solutions for the face and body.</description>
</item>
<item>
<title>InMode to Present at Upcoming Investor Conferences and Events</title>
<link>https://6ix.com/company/inmode-ltd/news/inmode-present-upcoming-investor-conferences-and-events-2025-05-07</link>
<guid isPermaLink="true">https://6ix.com/company/inmode-ltd/news/inmode-present-upcoming-investor-conferences-and-events-2025-05-07</guid>
<pubDate>Wed, 07 May 2025 04:00:00 GMT</pubDate>
<description>YOKNEAM, Israel, May 7, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the</description>
</item>
<item>
<title>InMode Granted Injunction Against Counterfeit Sales of Morpheus8 Radio Frequency Microneedling Devices and Needle Cartridges</title>
<link>https://6ix.com/company/inmode-ltd/news/inmode-granted-injunction-against-counterfeit-sales-morpheus8-radio-frequency</link>
<guid isPermaLink="true">https://6ix.com/company/inmode-ltd/news/inmode-granted-injunction-against-counterfeit-sales-morpheus8-radio-frequency</guid>
<pubDate>Tue, 06 May 2025 04:00:00 GMT</pubDate>
<description>IRVINE, Calif., May 6, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, reports that the US</description>
</item>
<item>
<title>InMode Reports First Quarter 2025 Financial Results; Quarterly Revenue of $77.9 Million Represents 3% Year-Over-Year Decrease</title>
<link>https://6ix.com/company/inmode-ltd/news/inmode-reports-first-quarter-2025-financial-results-quarterly-revenue-779-million</link>
<guid isPermaLink="true">https://6ix.com/company/inmode-ltd/news/inmode-reports-first-quarter-2025-financial-results-quarterly-revenue-779-million</guid>
<pubDate>Mon, 28 Apr 2025 04:00:00 GMT</pubDate>
<description>In April 2025, Completed Recent Share Repurchase Program of 6.95 Million Shares YOKNEAM, Israel, April 28, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD)</description>
</item>
</channel>
</rss>